KemPharm, Inc. (KMPH) Social Stream
Kempharm Inc (KMPH) Price Targets From Analysts
Use the tables below to see what analysts covering Kempharm Inc think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-01-20 | 2 | $28 | $10 | $19 | $5.1 | 272.55% |
| 2022-03-21 | 2 | $28 | $11 | $19.5 | $5.1 | 282.35% |
The Trend in the Analyst Price Target
KMPH's average price target has moved up $18 over the prior 22 months.
KMPH reports an average of 123.66% for its upside potential over the past 48 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-04-21 | 2 | 28 | 10 | 19.0 | 8.92 | 113% |
| 2021-07-10 | 2 | 28 | 10 | 19.0 | 13.31 | 42.75% |
| 2022-01-20 | 2 | 28 | 10 | 19.0 | 7.03 | 170.27% |
| 2022-01-31 | 2 | 28 | 11 | 19.5 | 7.21 | 170.46% |
| 2022-03-21 | 2 | 28 | 11 | 19.5 | 5.06 | 285.38% |
KMPH Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 2 | 0 | 0 | 0 | 0 | 2 |
The Trend in the Broker Recommendations
KMPH's average broker recommendation rating improved by 1 over the prior 48 weeks.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for KMPH as an investment opportunity.
- In terms of how Kempharm Inc fares relative to all US stocks, note that its number of analysts covering the stock is greater than 9.34% of that group.
- To contextualize these metrics, consider that out of all US stocks, Kempharm Inc's upside potential (average analyst target price relative to current price) is greater than 183.41% of them.
- To contextualize these metrics, consider that out of all US stocks, Kempharm Inc's variance in analysts' estimates is lower than -79.98% of them.
- In terms of how Kempharm Inc fares relative to Healthcare stocks, note that its average analyst price target is higher than 62.76% of that group.
In the Pharmaceutical Products industry, KMDA, KALV, and KALA are the three stocks most similar to Kempharm Inc regarding the price target and analyst recommendation information presented here.
Is KMPH a Buy, Hold or Sell? See the POWR Ratings now!